Renal hemodynamic and excretory responses in anesthetized rats to FK409, a novel nitric oxide donor

European Journal of Pharmacology

Volumn 321, Issue 2, 1997, Pages 195-200

  Urabe, Kazunori ^a   Matsumura, Yasuo ^a   Nishiura, Manabu ^a   Maeda, Kohsuke ^a   Morimoto, Shiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

FK409; N(G) Nitro L arginine; Nitric oxide (NO); Renal function; Urine formation

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; N(G) NITROARGININE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION; VASODILATATION;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HYPERTENSION, RENAL; INFUSIONS, INTRA-ARTERIAL; KIDNEY; MALE; NITRIC OXIDE; NITRO COMPOUNDS; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SODIUM; VASODILATOR AGENTS;

EID: 0031046078     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00945-4     Document Type: Article

References (33)

1. Alberola, A., J.M. Pinilla, T. Quesada, J.C. Romero, M.G. Salom and F.J. Salazar, 1992, Role of nitric oxide in mediating renal response to volume expansion, Hypertension 19, 780.
2. Bank, N., H.S. Aynedjian and G.A. Khan, 1994, Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats, Hypertension 24, 322.
3. Baylis, C., P. Harton and K. Engels, 1990, Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney, J. Am. Soc. Nephrol. 1, 875.
4. Baylis, C., K. Engels, L. Samsell and P. Harton, 1993, Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II, Am. J. Physiol. 264, F74.
5. Dananberg, J., R.S. Sider and R.J. Grekin, 1993, Sustained hypertension induced by orally administered nitro-L-arginine, Hypertension 21, 359.
6. G-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs, J. Pharmacol. Exp. Ther. 269, 529.
7. Egi, Y., Y. Matsumura, A. Miura, S. Murata and S. Morimoto, 1995, Interaction between nitric oxide and angiotensin II on antidiuresis and norephinephrine overflow induced by stimulation of renal nerves in anesthetized dogs, J. Cardiovasc. Pharmacol. 25, 187.
8. Fujita, K., Y. Matsumura, Y. Miyazaki, M. Takaoka and S. Morinoto, 1995, Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase, Eur. J. Pharmacol. 280, 311.
9. Gardiner, S.M., A.M. Compton, T. Bennett, R.M.J. Palmer and S. Moncada, 1990, Control of regional blood flow by endothelium-derived nitric oxide, Hypertension 15, 486.
10. Girerd, H.J., A.H. Hirsch, J.P. Cooke, V.J. Dzau and M.A. Creager, 1990, L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits, Circ. Res. 67, 1301.
11. G-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade, J. Pharmacol. Exp. Ther. 270, 1152.
12. Hayakawa, H., Y. Hirata, E. Suzuki, T. Sugimoto, H. Matsuoka, K. Kikuchi, T. Nagano, M. Hirobe and T. Sugimoto, 1993, Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats, Am. J. Physiol. 264, H1535.
13. Hino, M., M. Iwami, M. Okamoto, K. Yoshida, H. Haruta, M. Okuhara, J. Hosoda, M. Kohsaka, H. Aoki and H. Imanaka, 1989, FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus, J. Antibiot. 42, 1578.
14. Ignarro, L.J., 1990, Nitric oxide: a novel signal transduction mechanism for transcellular communication, Hypertension 16, 477.
15. Isono, T., Y. Koibuchi, N. Sato, A. Furuichi, M. Nishii, T. Yamamoto, J. Mori, M. Kohsaka and M. Ohtsuka, 1993, Vasorelaxant mechanism of the new vasodilator, FK409, Eur. J. Pharmacol. 246, 205.
16. Ito, S., C.S. Johnson and O.A. Carretero, 1991, Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole, J. Clin. Invest. 87, 1656.
17. Kita, Y., Y. Hirasawa, K. Maeda, E. Nishio and K. Yoshida, 1994a, Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409, Eur. J. Pharmacol. 257, 123.
18. Kita, Y., Y. Hirasawa, K. Yoshida and K. Maeda, 1994b, Antiplatelet activities of FK409, a new spontaneous NO releaser, Br. J. Pharmacol. 113, 385.
19. Kita, Y., R. Ozaki, S. Sakai, T. Sugimoto, Y. Hirasawa, M. Ohtsuka, H. Senoh, K. Yoshida and K. Maeda, 1994e, Antianginal effects of FK409, a new spontaneous NO releaser, Br. J. Pharmacol. 113, 1137.
20. G-nitro-arginine, inhibition of nitric oxide synthesis, on autoregulation of renal blood flow in dogs, Jpn. J. Pharmacol. 58, 147.
21. G-nitro-L-arginine methyl ester on renal function and blood pressure, Am. J. Physiol. 261, F1033.
22. Lücher, T.F., H.A. Bock, Z. Yang and D. Diederich, 1991, Endothelium-derived relaxing and contracting factors: perspectives in nephrology, Kidney Int. 39, 575.
23. Majid, D.S.A., A. Williams, P.J. Kadowitz and L.G. Navar, 1993a, Renal responses to intra-arterial administration of nitric oxide donor in dogs, Hypertension 22, 535.
24. Majid, D.S.A., A. Williams and L.G. Navar, 1993b, Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic response in anesthetized dogs, Am. J. Physiol. 264, F79.
25. G-nitro-L-arginine, a nitric oxide synthase inhibitor, Biol. Pharm. Bull. 18, 496.
26. Moncada, S., R.M.J. Palmer and E.A. Higgs, 1991a, Nitric oxide: physiology, pathophysiology, and pharmacolgy, Pharmacol. Rev. 43, 109.
27. Moncada, S., D.D. Rees, R. Schulz and R.M.J. Palmer, 1991b, Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo, Proc. Natl. Acad. Sci. USA 88, 2166.
28. Pollock, D.M., J.S. Polakowski, B.J. Divish and T.J. Opgenorth, 1993, Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition, Hypertension 21, 660.
29. Salom, M.G., V. Lahera, F. Miranda-Guardiola and J.C. Romero, 1992, Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs, Am. J. Physiol. 262, F718.
30. Tolins, J.P., R.M.J. Palmer, S. Moncada and L. Raij, 1990, Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses, Am. J. Physiol. 258, H655.
31. Vurek, G.G. and S.E. Pegram, 1966, Fluorometric method for the determination of nanogram quantities of inulin, Anal. Biochem. 16, 409.
32. Yamada, H., F. Yoneyama, K. Satoh and N. Taira, 1991, Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog, Br. J. Pharmacol. 103, 1713.
33. Yoshida, M., M. Kikukawa, H. Hisa and S. Satoh, 1996, Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8), Br. J. Pharmacol. 117, 885.